Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

Patients who require insulin glargine to improve metabolic control and to avoid microvascular and macrovascular complications of diabetes mellitus should, therefore, continue their treatment with ...

GDM is managed with medical nutritional therapy (MNT), exercise ... GDM should be differentiated from types 1 and 2 diabetes mellitus. Treatment options should be discussed.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Individuals with diabetes mellitus usually present ... Ideally, when DESs are implanted, long-term treatment with dual antiplatelet therapy should be considered because of the risk of late stent ...

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Despite all the scientific advances in its diagnosis and treatment, the prevalence of diabetes mellitus has grown dramatically in ... that focus their work on this condition. The nutrition therapy ...

Researchers has discovered a specific protein IL-35 that protects the immune system by lowering particular immune cells that produce inflammatory chemicals, thereby reducing pancreatic cell ...

Alnylam Pharmaceuticals will suspend further clinical development of its potential treatment for type 2 diabetes mellitus.